Published in Clin Exp Rheumatol on April 30, 1992
Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest (1995) 1.75
Antiphospholipid syndrome: an overview. CMAJ (2003) 1.05
Antiphospholipid antibodies: paradigm in transition. J Neuroinflammation (2009) 0.94
Anti-beta2-glycoprotein I (GPI) autoantibodies, annexin V binding and the anti-phospholipid syndrome. Clin Exp Immunol (2000) 0.87
Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration. Clin Exp Immunol (1995) 0.85
Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: a preliminary study. BMC Neurol (2007) 0.84
Screening of a HUAEC cDNA library identifies actin as a candidate autoantigen associated with carotid atherosclerosis. Clin Exp Immunol (2004) 0.84
Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations. Thromb Res (2014) 0.80
Association of anticardiolipin antibodies with vascular injury: possible mechanisms. Postgrad Med J (2000) 0.78
Clinical setting of patients with systemic sclerosis by serum autoantibodies. Clin Rheumatol (1997) 0.76
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum (1999) 7.67
Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum (1993) 7.14
Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet (1983) 6.71
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum (2001) 4.06
Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis (1987) 3.62
Anti-phospholipid antibodies. Clin Rheum Dis (1985) 3.43
Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol (1985) 3.38
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis (2007) 3.32
The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) (1989) 3.13
Fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells. J Thromb Haemost (2004) 2.79
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis (2010) 2.52
Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol (1985) 2.51
Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med (1986) 2.35
Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis. Arthritis Rheum (1995) 2.09
Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody. Br J Haematol (1985) 2.07
Affinity purified anti-cardiolipin and anti-DNA antibodies. J Clin Lab Immunol (1985) 1.92
Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation (1999) 1.82
Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement. Ann Rheum Dis (2004) 1.80
Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL): results of a prospective, single-arm multicentre study. Leukemia (2009) 1.80
Syndrome of the black swan. Br J Rheumatol (1987) 1.80
Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome. Clin Exp Immunol (2014) 1.78
Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome. Ann Rheum Dis (1989) 1.73
Inhibition of neutrophil oxidative metabolism by nimesulide. Agents Actions (1987) 1.73
Anticardiolipin antibodies--clinical associations. Postgrad Med J (1986) 1.71
Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus (1999) 1.70
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis (2009) 1.69
QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block. Arthritis Rheum (2000) 1.65
Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest (1996) 1.65
Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB/c mice. Arthritis Rheum (1998) 1.63
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. Rheumatology (Oxford) (2002) 1.61
Anticardiolipin antibodies: occurrence in Behçet's syndrome. Ann Rheum Dis (1984) 1.61
Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype. Arthritis Rheum (2001) 1.60
Crossreactivity of antiphospholipid antibodies. J Clin Lab Immunol (1985) 1.60
Systemic lupus erythematosus and pregnancy: a prospective study. Clin Exp Rheumatol (1993) 1.60
Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome. Obstet Gynecol (1997) 1.59
Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. Eur J Endocrinol (1995) 1.58
Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol (1985) 1.56
HLA-DR antigens and anticardiolipin antibodies in northern Italian systemic lupus erythematosus patients. Arthritis Rheum (1988) 1.48
Recurrent adverse pregnancy outcome and antiphospholipid antibodies. Am J Obstet Gynecol (1990) 1.47
Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation. Arthritis Rheum (1997) 1.45
Neonatal lupus: fetal myocarditis progressing to atrioventricular block in triplets. Lupus (2003) 1.45
Role of p38 mitogen-activated protein kinase in antiphospholipid antibody-mediated thrombosis and endothelial cell activation. J Thromb Haemost (2007) 1.45
Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study. Rheumatology (Oxford) (2007) 1.44
Transfer of experimental antiphospholipid syndrome by bone marrow cell transplantation. The importance of the T cell. Arthritis Rheum (1995) 1.44
Anticardiolipin antibodies and binding of anionic phospholipids and serum protein. Lancet (1990) 1.43
Induction of high levels of anticardiolipin antibodies in mice by immunization with beta 2-glycoprotein I does not cause fetal death. Am J Obstet Gynecol (1995) 1.41
Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. Lupus (2002) 1.41
The PLAT Study: a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients. Atherosclerosis (1991) 1.40
Cortisol secretion in patients on simvastatin. Lancet (1990) 1.40
Chemicals and drugs as triggers of food-associated disorder. Ann Allergy (1988) 1.39
Thrombotic events in patients with systemic sclerosis treated with iloprost. Arthritis Rheum (1998) 1.39
Antiphospholipid antibodies cross-reacting with erythrocyte membranes. A case report. Clin Exp Rheumatol (1992) 1.38
Anticardiolipin antibodies: to be or not to be detectable. Clin Exp Rheumatol (2001) 1.38
The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med (1996) 1.38
Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis (1987) 1.38
Hyponatraemia and seizure due to overdose of trazodone. BMJ (1992) 1.37
Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome. Thromb Haemost (1995) 1.35
Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis (1988) 1.35
HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection. Lancet (1986) 1.31
Anticardiolipin antibodies and lupus anticoagulant. Lancet (1984) 1.30
TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS (1994) 1.29
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis (2008) 1.28
European consensus statement on the terminology used in the management of lupus glomerulonephritis. Lupus (2009) 1.28
Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and micropolyarteritis. Clin Exp Immunol (1990) 1.26
Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study. Arthritis Rheum (2010) 1.26
Updating on the pathogenesis of systemic lupus erythematosus. Autoimmun Rev (2010) 1.24
Anti-phospholipid and anti-mitochondrial type M5 antibodies in systemic lupus erythematosus. Clin Exp Rheumatol (1986) 1.22
Chorea in systemic lupus erythematosus and "lupus-like" disease: association with antiphospholipid antibodies. Semin Arthritis Rheum (1987) 1.21
Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol (2001) 1.21
IgG subclass and light chain distribution of anticardiolipin and anti-DNA antibodies in systemic lupus erythematosus. Ann Rheum Dis (1988) 1.21
Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. J Neurol Sci (2001) 1.20